Abstract
Advances in endoscopic and therapeutic hysteroscopic technology have made the removal of submucosal fibroids possible in the outpatient setting. Removal of submucosal fibroids can be particularly challenging in the outpatients due to intramural components of some submucosal fibroids and the hard consistency of fibroids which makes specimen retrieval rather difficult through the endocervical canal. Fibroids which are <2 cm and completely intracavitary are easier to remove in the outpatients. Specimen retrieval can be addressed either by slicing the fibroid using bipolar electrodes, by using a hysteroscopic morcellator or leaving the fibroid in the uterine cavity after enucleation to be expelled with uterine contractions. Patient acceptability appears to be high in a small number of retrospective case series published in the literature. Further reports and data from prospective trials would be beneficial in improving our understanding of this procedure which appears to be performed by a relatively small number of centres.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–7.
Saridogan E, Cutner A. Endoscopic management of uterine fibroids. Hum Fertil (Camb). 2006;9(4):201–8.
Clark TJ, Gupta JK. Handbook of outpatient hysteroscopy: a complete guide to diagnosis and therapy. London: Hodder Arnold; 2005.
Gulumser C, Narvekar N, Pathak M, Palmer E, Parker S, Saridogan E. See-and-treat outpatient hysteroscopy: an analysis of 1109 examinations. Reprod Biomed Online. 2010;20(3):423–9.
RCOG, BSGE. Best practice in outpatient hysteroscopy. London: RCOG; 2011. An important evidence-based text on the practice of outpatient hysteroscopy.
Bettocchi S, Ceci O, Di VR, Pansini MV, Pellegrino A, Marello F, et al. Advanced operative office hysteroscopy without anaesthesia: analysis of 501 cases treated with a 5 Fr. bipolar electrode. Hum Reprod. 2002;17(9):2435–8. First article which described the commonly used minihysteroscopic removal of submucosal fibroids in the outpatient setting.
Saridogan E. Surgical treatment of fibroids in heavy menstrual bleeding. Womens Health (Lond Engl). 2016;12(1):53–62.
Papalampros P, Gambadauro P, Papadopoulos N, Polyzos D, Chapman L, Magos A. The mini-resectoscope: a new instrument for office hysteroscopic surgery. Acta Obstet Gynecol Scand. 2009;88(2):227–30.
Penketh RJ, Bruen EM, White J, Griffiths AN, Patwardhan A, Lindsay P, et al. Feasibility of resectoscopic operative hysteroscopy in a UK outpatient clinic using local anesthetic and traditional reusable equipment, with patient experiences and comparative cost analysis. J Minim Invasive Gynecol. 2014;21(5):830–6.
Emanuel MH, Wamsteker K. The intra uterine morcellator: a new hysteroscopic operating technique to remove intrauterine polyps and myomas. J Minim Invasive Gynecol. 2005;12(1):62–6.
Munro MG. Hysteroscopic myomectomy of FIGO type 2 leiomyomas under local anesthesia: bipolar radiofrequency needle-based release followed by electromechanical morcellation. J Minim Invasive Gynecol. 2016;23(1):12–3.
Haimovich S, Mancebo G, Alameda F, Agramunt S, Sole-Sedeno JM, Hernandez JL, et al. Feasibility of a new two-step procedure for office hysteroscopic resection of submucous myomas: results of a pilot study. Eur J Obstet Gynecol Reprod Biol. 2013;168(2):191–4. The largest case series with the use of two-step removal of submucosal fibroids in the outpatient setting.
Bettocchi S, Di Spiezio SA, Ceci O, Nappi L, Guida M, Greco E, et al. A new hysteroscopic technique for the preparation of partially intramural myomas in office setting (OPPIuM technique): a pilot study. J Minim Invasive Gynecol. 2009;16(6):748–54.
Haimovich S, Lopez-Yarto M, Urresta AJ, Saavedra TA, Hernandez JL, Carreras CR. Office hysteroscopic laser enucleation of submucous myomas without mass extraction: a case series study. Biomed Res Int. 2015;2015:905204.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Ertan Saridogan declares personal fees from Ethicon and Gedeon Richter in the form of honoraria for provision of training to healthcare professionals.
Christine S. Deguara declares no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Uterine Fibroids
Rights and permissions
About this article
Cite this article
Saridogan, E., Deguara, C.S. Office Hysteroscopic Treatment of Uterine Fibroids. Curr Obstet Gynecol Rep 5, 106–109 (2016). https://doi.org/10.1007/s13669-016-0152-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13669-016-0152-4